If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, LATAM (LTM) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Interest from the US government potentially signals Intel as a critical player in U.S. semiconductor and national security strategy. The company's renewed strategy focuses on revamping its foundry business, launching Panther Lake on 18A, and moving toward full-stack AI solutions. The stock trades at deep valuation discounts, reflecting low expectations and past execution missteps.

Bitcoin's record-breaking run fuels optimism for crypto-linked stocks like IBKR, HOOD and PYPL with strong 2025 growth potential.

Analog Devices' Q3 results are set for strong growth on industrial and healthcare demand, with inventory recovery boosting momentum.

RADNOR, Pa. , Aug. 15, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Replimune Group, Inc. ("Replimune") (NASDAQ: REPL) on behalf of those who purchased or otherwise acquired Replimune securities between November 22, 2024, and July 21, 2025, inclusive (the "Class Period").

Circle Internet Group posts strong Q2 earnings and revenue growth, driven by USDC adoption, but shares slide 15% over growth concerns.

TEN, CZNC and NGG made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 15, 2025.

Applied Materials (NASDAQ: AMAT) shares plunged on Friday, trading at $164.31 as of market open, a 12.71% drop from Thursday's close of $188.24.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sable Offshore To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Sable Offshore between May 19, 2025 and June 3, 2025 and/or pursuant to Sable's May 21, 2025 secondary public offering (the "SPO") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 15, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national …

Betting against growth and tech equities was a winning idea for a time earlier this year. But that span was fleeting.

The tech ETF space offers plenty of important questions for investors.

Ample volatility and shifting rate expectations have sent investors on an avid search for stability and diversification. Many investors are now looking to the next frontier of fixed income ETFs — asset-backed securities — as private lenders fill a big financing void created by the exit of traditional banks.

Fortinet's stock drop is excessive; strong management, scalable products, and SASE growth support my long-term bullish thesis. Q2 results were solid: EPS beat, billings guidance raised, and firewall renewal cycle is progressing as planned, despite margin compression from investments. Market overreacted to lower product segment growth, but hardware is just an enabler for high-margin services, which remain the core value driver.

NEXE Innovations Inc (TSX-V:NEXE, OTC:NEXNF) said on Friday it has made another delivery to ecoBeans Coffee Inc., following strong early sales on Amazon Canada. Following the launch of its products on Amazon in April 2025, ecoBeans reported that revenues for the two months following the launch were more than four times higher than during the initial period, driven by organic customer adoption across Canada.

Roivant Sciences Ltd.'s Vant model gives it risk-isolated development, monetization flexibility, and diversified optionality. ROIV's main value drivers are Immunovant, Priovant, Pulmovant, and Genevant. All of these Vants are progressing well in 2025. However, its main near-term catalyst is Brepocitinib's Phase 3 in dermatomyositis. This could become the first approved therapy for this condition.

Warren Buffett's $1.6B stake in UnitedHealth Group Incorporated via Berkshire Hathaway is a game-changing endorsement, shifting market sentiment and providing a strong catalyst for a narrative turnaround. Despite ongoing DOJ investigations and Medicare Advantage margin pressures, the risk/reward profile has materially improved thanks to this high-profile buy-in. Management's confidence is reflected in a 5% dividend hike and strategic exits from unprofitable contracts, though fundamental challenges remain for 2025-2026.

The Federal Reserve is squarely in focus, with political pressure from the Trump Administration, in-line inflation figures, and weaker data on jobs boosting the chance of interest rate cuts. How many will we get?

Hesai Group reported another quarter of record shipments in Q2. The company didn't provide much guidance on upcoming quarters, but tailwinds in the industry stand strong. The Q2 report showed positive GAAP operating income. Hesai's prudent cost control has enabled very rapid operating leverage, setting up great margin expectations. HSAI stock's surge has been warranted. I estimate a fair value of $29.15.

Advance Auto Parts, Inc. has stabilized sales, but margin expansion is challenged by tariffs, restructuring costs, and ongoing store investments. Recent debt issuance and a strong cash position support AAP liquidity, but free cash flow remains negative due to inventory and capex needs. Management's aggressive 2027 margin and earnings targets appear optimistic given operational headwinds and required modernization spending.

ST. LOUIS--(BUSINESS WIRE)--Caleres (NYSE: CAL) today announced Kathleen Welter has joined the company as chief human resources officer. Welter will oversee all human resources functions for the company's portfolio of brands and its more than 9,000 Associates worldwide, including recruitment, talent management, training, culture, compensation, benefits and labor law compliance. Welter will be a member of the company's leadership team and will report to President and CEO Jay Schmidt. She will be.